Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation
- 10 September 2004
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Eye
- Vol. 19 (7), 747-751
- https://doi.org/10.1038/sj.eye.6701636
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedemaActa Ophthalmologica Scandinavica, 2003
- Noninfectious Endophthalmitis Associated With Intravitreal Triamcinolone InjectionAmerican Journal of Ophthalmology, 2003
- Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injectionOphthalmology, 2003
- Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathyBritish Journal of Ophthalmology, 2000
- The national diabetic retinopathy laser treatment audit III. Clinical outcomesEye, 1999
- Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.Australian and New Zealand Journal of Ophthalmology, 1998
- Progressive Enlargement of Laser Scars Following Grid Laser Photocoagulation for Diffuse Diabetic Macular EdemaAmerican Journal of Ophthalmology, 1991
- Early Treatment Diabetic Retinopathy Study Design and Baseline Patient CharacteristicsOphthalmology, 1991
- Photocoagulation for Diabetic Macular EdemaAmerican Journal of Ophthalmology, 1985
- Treatment of Intraocular Proliferation with Intravitreal Injection of Triamcinolone AcetonideAmerican Journal of Ophthalmology, 1980